Oijen, M.G.H. van

liver patient polycystic lanreotide volume disease polycystic liver disease liver volume treatment month kidney study brosi 12 months polycystic kidney disease adpkd liver fi brosis kidney volume radboud university nijmegen change result biopsy 6 months signi range liver biopsy effect polycystic liver placebo fibrotest trial hepatology ficant table fibroscan nijmegen university symptom autosomal department mutation hepatic gastroenterology baseline psoriasis somatostatin psoriasis patients lanreotide treatment somatostatin analogues group keimpema metavir diagnosis value aliment pharmacol netherland analogue adpkd patients score octreotide polycystic kidneys cohort follow-up polycystic livers hepatitis c liver cysts level figure increase serum assessment health hepatitis difference prkcsh drenth histology number therapy mtx-induced